NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

OPTHEA LIMITED (OPT)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of OPT: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare Melbourne
Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000OPT2
Address: Suite 0403, Level 4, 650 Chapel Street, South Yarra Victoria 3141
Tel:  (03) 9826 0399Fax: (03) 9824 0083

Date first listed: 18/04/1991

Sector: Pharmaceuticals Biotechnology & Life Sciences Industry Group: XHJ
Activities: Opthea is a drug development company developing innovative, biologics-based therapies for the treatment of eye disease

News & Events

Expand this box to read and print

The company has announced the results of its COAST Phase 3 clinical trial. The trial did not meet the primary endpoint of mean change in best corrected visual acuity from baseline to week 52.

24/03/2025

The securities of Opthea Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of OPT, pending the release of an announcement regarding clinical trial results.

19/03/2025

The following Options of Opthea Limited will be reinstated to quotation from the commencement of trading on Thursday, 18 July 2024: OPTOB

17/07/2024

The options of Opthea Limited will be suspended immediately in accordance with Listing Rule 17.3, as there will be no deferred settlement trading. The options are expected to be quoted on a normal settlement basis on Thursday, 18 July 2024. The suspension only applies to OPT's options (ASX: OPTOB) and does not apply to any other quoted securities of OPT.

11/07/2024

The suspension of trading in the options (ASX: OPTOA) of Opthea Limited will be lifted immediately.

22/09/2023

The options of Opthea Limited will be suspended immediately in accordance with Listing Rule 17.3, as there will be no deferred settlement trading. The options are expected to be quoted on a normal settlement basis on Friday, 22 September 2023. The suspension only applies to OPT's options and does not apply to any other quoted securities of OPT.

15/09/2023

name changed from Circadian Technologies Limited

14/12/2015

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    04/04/2019Megan Baldwin-667,000$0.660$440,220
    24/04/2017Michael Sistenich200,178$0.930$186,166
    24/05/2013Robert Klupacs5,000$0.250$1,250
    22/05/2013Robert Klupacs42,000$0.260$10,920
    16/05/2013Tina McMeckan30,000$0.251$7,539

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Jeremy LevinChairman12/10/2020
    Frederic GuerardCEO27/10/2023
    Tom ReillyCFO28/10/2024
    Julia HallerIndependent Director01/06/2021
    Anshul ThakralNon Exec Director09/06/2023
    Kathy ConnellNon Exec Director15/11/2024
    Sujal ShahNon Exec Director04/04/2024
    Lawrence GozlanNon Exec Director24/07/2020
    Quinton OswaldDirector21/04/2022
    Susan OrrDirector21/04/2022
    Karen AdamsCompany Secretary

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Megan BaldwinExecutive Director24/02/201415/11/2024
    Daniel GeffkenCFO09/09/202428/10/2024
    Peter LangCFO27/10/202309/09/2024
    Daniel SpiegelmanIndependent Director10/09/202004/04/2024
    Timothy MorrisCFO24/10/202227/10/2023
    Michael SistenichNon Exec Director30/11/201509/06/2023
    Judith RobertsonIndependent Director01/06/202103/01/2022
    Michael TonroeCFO19/05/201424/06/2021
    Geoffrey KemplerChairman30/11/201512/10/2020
    Dominique FisherNon Exec Chairman04/08/200530/11/2015
    Tina McMeckanNon Exec Director19/01/200830/11/2015
    Russell HowardNon Exec Director03/12/201330/11/2015
    Mark PrynCFO10/09/201319/05/2014
    Robert KlupacsManaging Director, CEO01/03/200803/12/2013
    Don ClarkeNon Exec Director01/09/200529/11/2013
    Steven ZammitCFO25/02/201310/09/2013
    Susan MaddenCFO14/05/201028/02/2013
    Errol MaltaNon Exec Director20/08/200901/10/2012

    Date of first appointment, title may have changed.